Fujifilm Hldgs Corp (FUJIY) 30.4200 $FUJIY
FUJIFILM Completes Acquisition of Kalon Biotherapeutics
Business Wire - Thu Dec 18, 1:17PM CST
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and manufacturing of life-saving biopharmaceuticals and biotechnology while providing FUJIFILM Diosynth Biotechnologies with expanded capacity for its growing vaccine capabilities. The completion of the previously announced Purchase Interest Agreement of Kalon Biotherapeutics, LLC, was made with the owners of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System. The announcement was made jointly today by Governor Rick Perry; officials of FUJIFILM Corporation, FDBU and Mitsubishi Corporation; Kalon Biotherapeutics LLC; and the Texas A&M System. Going forward, the company is now known as FUJIFILM Diosynth Biotechnologies Texas, LLC.
Global Mammography Systems Market Forecast and Opportunity Assessment 2007 - 2020
M2 - Tue Dec 16, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/h2x2hm/global) has announced the addition of the "Global Mammography Systems Market Forecast and Opportunity Assessment, 2007 - 2020" report to their offering. The global mammography market is projected to be $2.8 billion by 2020 Breast cancer, one of the most common types of cancer affecting women worldwide, represents about a quarter of all cancer deaths in women. This high mortality indicates the unmet needs of patients diagnosed with breast cancer and has resulted in a surge in demand for mammography devices in developing countries and upgrade or replacement to digital mammography systems, Full Field Digital Mammography (FFDM) and 3-D mammography systems from analogue mammography systems in developed nations. Also, the acceptance of early diagnosis has increased among people as a result of enhanced breast cancer awareness, initiation of breast screening programs, evolution in technologies and steps to improve reimbursement policies by various governments. Yet factors like high risk of exposure to radiation, false diagnosis, uncomfortable procedure, risk of occurrence of interval cancer and lack of female technicians are restraining the market growth. Among mammography systems, digital mammography has the largest market in the US, Europe, Australia and Japan but it is relatively a newer technology for the underpenetrated markets for mammography, like the rest of the Asia Pacific. For the rest of APAC and other developing economies, FFDM systems would become major centers of growth in the longer run. Key Topics Covered: 1. Charts & Tables 2. Global Market for Mammography Systems Devices (2007-2020) 3. North America Market for Mammography Systems Devices (2007-2020) 4. US Market for Mammography Systems (2007-2020) 5. Canada Market for Mammography Systems (2007-2020) 6. Europe Market for Mammography Systems Devices (2007-2020) 7. France Market for Mammography Systems (2007-2020) 8. Germany Market for Mammography Systems (2007-2020) 9. Italy Market for Mammography Systems (2007-2020) 10. Spain Market for Mammography Systems (2007-2020) 11. Netherlands Market for Mammography Systems (2007-2020) 12. UK Market for Mammography Systems (2007-2020) 13. Bulgaria Market for Mammography Systems (2007-2020) 14. Russia Market for Mammography Systems (2007-2020) 15. Asia Pacific Market for Mammography Systems Devices (2007-2020) 16. Australia Market for Mammography Systems (2007-2020) 17. China Market for Mammography Systems (2007-2020) 18. India Market for Mammography Systems (2007-2020) 19. Japan Market for Mammography Systems (2007-2020) 20. Recent Events and Developments 21. Company and Product Profiles - Carestream Health - Esaote - FUJIFILM Holdings Corp. - GE Healthcare - Hitachi Ltd. - Hologic Inc. - Internazionale Medico Scientifica Srl. - Mindray Medical International Limited - PerkinElmer Inc. - Philips Healthcare - Planmed Oy - Sectra AB - Shimadzu Corp. - Siemens Healthcare - SonoCine Inc. - Toshiba Medical Systems Corp. For more information visit http://www.researchandmarkets.com/research/h2x2hm/global
MR: 26.87 (+0.30), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
Looking for Value? Why It Might Be Time to Try FUJIFILM Holdings (FUJIY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:36AM CST
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
Ultrasound Market worth $6.2 Billion by 2019 - Prominent Players in this Market - Analogic Corporation (U.S.), Esaote S.p.A (Italy) & FUJIFILM Holdings Corporation (Japan)
M2 - Fri Dec 12, 3:56AM CST
The report "Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) - Global Forecast to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the World (RoW).
ALOG: 86.43 (+0.32)
Ultrasound Market Worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Tue Dec 09, 2:50AM CST
The global ultrasound market was dominated by General Electric Company (U.S.) in 2013, followed by Koninklijke Philips N.V. (The Netherlands). Other players include FUJIFILM Holdings Corporation (Japan), Mindray Medical International Limited (China), Hitachi Ltd. (Japan), Samsung Electronics Co. Ltd. (South Korea), Siemens AG (Germany), and Toshiba Corporation (Japan).
MR: 26.87 (+0.30)
Ebola Stocks on the Rise as Death Toll Hits 5,000
ACCESSWIRE - Mon Dec 01, 11:28AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2014 / The death toll from the current Ebola outbreak has nearly hit 5,000 according to the World Health Organization (WHO). While the spread seems to be thankfully slowing, the Ebola stock phenomenon has now transitioned from fear-based speculative buying to concrete capital flows. Lakeland Industries (NASDAQ:LAKE), after surging on the mere news of Ebola and speculation that this would increase demand for the company's hazmat suits, is now surging again on the news that, indeed, the suits are starting to sell. Lakeland last week announced total orders of over one million Ebola suits from both government agencies and private sector customers. Sales will be accretive to earnings after January 31, 2015.
APT: 2.55 (-0.03), NLNK: 39.08 (+1.36), LAKE: 8.94 (+0.07), GSK: 42.85 (+0.11)
Fujifilm flu drug could get Ebola indication by year end
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 7:26AM CST
Will Fujifilm (FUJIY) Stock Be Affected Today by This Analyst Action?
at The Street - Tue Nov 04, 11:15AM CST
Shares of Fujifilm (FUJIY) are down in early afternoon trading despite being upgraded to 'hold' from 'underperform' by Jefferies earlier today.
FUJIFILM (FUJIY) Stock Higher Today on Kalon Purchase
at The Street - Mon Oct 27, 10:49AM CDT
The company will acquire an American maker of vaccines to order, gaining a foothold in a business with the prospect of global growth.
Fujifilm buys a stake in Texas vaccine developer
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 5:50AM CDT
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan
GlobeNewswire - Tue Sep 09, 7:00AM CDT
Cempra, Inc. (Nasdaq:CEMP) today announced the receipt of a $10 million milestone payment from Toyama Chemical Co., a subsidiary of FUJIFILM Holdings Corporation, triggered by Toyama's progress of its solithromycin clinical development program in Japan, the world's second largest antibiotic market. The payment was made following Toyama's receipt of regulatory clearance to begin a Phase 2 trial of solithromycin in Japan following successful completion of a Phase 1 study.
CEMP: 20.66 (+0.78)
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
BSX: 13.13 (+0.07), SNN: 38.18 (+0.14), SYK: 96.00 (-0.61)
Japan ready to offer flu drug for Ebola treatment
By MARI YAMAGUCHI - AP - Mon Aug 25, 12:44PM CDT
TOKYO (AP) — Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak.
How Will Fujifilm (FUJIY) Stock Be Boosted By Ebola Drug Approval?
at The Street - Thu Aug 07, 11:54AM CDT
U.S. government researchers are working to get an experimental flu drug from the Japan-based company quickly approved to treat Ebola.
Fujifilm's Q1 Earnings Rise; Revenues Drop Year over Year - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:35AM CDT
Fujifilm (FUJIY) reports mixed results for fiscal first-quarter 2015, with year over year improvement in net income while revenues declined.
AIXG: 10.99 (-0.04), MKSI: 37.24 (-0.01)
TriQuint Beats on Q2 Earnings; Bullish Outlook for 2H14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:20PM CDT
TriQuint (TQNT) reported adjusted earnings of 13 cents per share, beating the Zacks Consensus Estimate of 3 cents. The company benefited from its portfolio restructuring efforts toward higher-value solutions.
TQNT: 27.72 (+0.50), YELP: 53.00 (-0.36), RFMD: 16.59 (+0.29)
Why FUJIFILM Holdings (FUJIY) is Such a Great Value Stock Pick Right Now - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 7:37AM CDT
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
FUJIFILM Completes Acquisition of Kalon Biotherapeutics
Business Wire - Thu Dec 18, 1:17PM CST
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and manufacturing of life-saving biopharmaceuticals and biotechnology while providing FUJIFILM Diosynth Biotechnologies with expanded capacity for its growing vaccine capabilities. The completion of the previously announced Purchase Interest Agreement of Kalon Biotherapeutics, LLC, was made with the owners of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System. The announcement was made jointly today by Governor Rick Perry; officials of FUJIFILM Corporation, FDBU and Mitsubishi Corporation; Kalon Biotherapeutics LLC; and the Texas A&M System. Going forward, the company is now known as FUJIFILM Diosynth Biotechnologies Texas, LLC.
Global Mammography Systems Market Forecast and Opportunity Assessment 2007 - 2020
M2 - Tue Dec 16, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/h2x2hm/global) has announced the addition of the "Global Mammography Systems Market Forecast and Opportunity Assessment, 2007 - 2020" report to their offering. The global mammography market is projected to be $2.8 billion by 2020 Breast cancer, one of the most common types of cancer affecting women worldwide, represents about a quarter of all cancer deaths in women. This high mortality indicates the unmet needs of patients diagnosed with breast cancer and has resulted in a surge in demand for mammography devices in developing countries and upgrade or replacement to digital mammography systems, Full Field Digital Mammography (FFDM) and 3-D mammography systems from analogue mammography systems in developed nations. Also, the acceptance of early diagnosis has increased among people as a result of enhanced breast cancer awareness, initiation of breast screening programs, evolution in technologies and steps to improve reimbursement policies by various governments. Yet factors like high risk of exposure to radiation, false diagnosis, uncomfortable procedure, risk of occurrence of interval cancer and lack of female technicians are restraining the market growth. Among mammography systems, digital mammography has the largest market in the US, Europe, Australia and Japan but it is relatively a newer technology for the underpenetrated markets for mammography, like the rest of the Asia Pacific. For the rest of APAC and other developing economies, FFDM systems would become major centers of growth in the longer run. Key Topics Covered: 1. Charts & Tables 2. Global Market for Mammography Systems Devices (2007-2020) 3. North America Market for Mammography Systems Devices (2007-2020) 4. US Market for Mammography Systems (2007-2020) 5. Canada Market for Mammography Systems (2007-2020) 6. Europe Market for Mammography Systems Devices (2007-2020) 7. France Market for Mammography Systems (2007-2020) 8. Germany Market for Mammography Systems (2007-2020) 9. Italy Market for Mammography Systems (2007-2020) 10. Spain Market for Mammography Systems (2007-2020) 11. Netherlands Market for Mammography Systems (2007-2020) 12. UK Market for Mammography Systems (2007-2020) 13. Bulgaria Market for Mammography Systems (2007-2020) 14. Russia Market for Mammography Systems (2007-2020) 15. Asia Pacific Market for Mammography Systems Devices (2007-2020) 16. Australia Market for Mammography Systems (2007-2020) 17. China Market for Mammography Systems (2007-2020) 18. India Market for Mammography Systems (2007-2020) 19. Japan Market for Mammography Systems (2007-2020) 20. Recent Events and Developments 21. Company and Product Profiles - Carestream Health - Esaote - FUJIFILM Holdings Corp. - GE Healthcare - Hitachi Ltd. - Hologic Inc. - Internazionale Medico Scientifica Srl. - Mindray Medical International Limited - PerkinElmer Inc. - Philips Healthcare - Planmed Oy - Sectra AB - Shimadzu Corp. - Siemens Healthcare - SonoCine Inc. - Toshiba Medical Systems Corp. For more information visit http://www.researchandmarkets.com/research/h2x2hm/global
MR: 26.87 (+0.30), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
Looking for Value? Why It Might Be Time to Try FUJIFILM Holdings (FUJIY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 7:36AM CST
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
Ultrasound Market worth $6.2 Billion by 2019 - Prominent Players in this Market - Analogic Corporation (U.S.), Esaote S.p.A (Italy) & FUJIFILM Holdings Corporation (Japan)
M2 - Fri Dec 12, 3:56AM CST
The report "Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) - Global Forecast to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the World (RoW).
ALOG: 86.43 (+0.32)
Ultrasound Market Worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets
PRWeb - Tue Dec 09, 2:50AM CST
The global ultrasound market was dominated by General Electric Company (U.S.) in 2013, followed by Koninklijke Philips N.V. (The Netherlands). Other players include FUJIFILM Holdings Corporation (Japan), Mindray Medical International Limited (China), Hitachi Ltd. (Japan), Samsung Electronics Co. Ltd. (South Korea), Siemens AG (Germany), and Toshiba Corporation (Japan).
MR: 26.87 (+0.30)
Ebola Stocks on the Rise as Death Toll Hits 5,000
ACCESSWIRE - Mon Dec 01, 11:28AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2014 / The death toll from the current Ebola outbreak has nearly hit 5,000 according to the World Health Organization (WHO). While the spread seems to be thankfully slowing, the Ebola stock phenomenon has now transitioned from fear-based speculative buying to concrete capital flows. Lakeland Industries (NASDAQ:LAKE), after surging on the mere news of Ebola and speculation that this would increase demand for the company's hazmat suits, is now surging again on the news that, indeed, the suits are starting to sell. Lakeland last week announced total orders of over one million Ebola suits from both government agencies and private sector customers. Sales will be accretive to earnings after January 31, 2015.
APT: 2.55 (-0.03), NLNK: 39.08 (+1.36), LAKE: 8.94 (+0.07), GSK: 42.85 (+0.11)
Fujifilm flu drug could get Ebola indication by year end
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 7:26AM CST
Will Fujifilm (FUJIY) Stock Be Affected Today by This Analyst Action?
at The Street - Tue Nov 04, 11:15AM CST
Shares of Fujifilm (FUJIY) are down in early afternoon trading despite being upgraded to 'hold' from 'underperform' by Jefferies earlier today.
FUJIFILM (FUJIY) Stock Higher Today on Kalon Purchase
at The Street - Mon Oct 27, 10:49AM CDT
The company will acquire an American maker of vaccines to order, gaining a foothold in a business with the prospect of global growth.
Fujifilm buys a stake in Texas vaccine developer
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 5:50AM CDT
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan
GlobeNewswire - Tue Sep 09, 7:00AM CDT
Cempra, Inc. (Nasdaq:CEMP) today announced the receipt of a $10 million milestone payment from Toyama Chemical Co., a subsidiary of FUJIFILM Holdings Corporation, triggered by Toyama's progress of its solithromycin clinical development program in Japan, the world's second largest antibiotic market. The payment was made following Toyama's receipt of regulatory clearance to begin a Phase 2 trial of solithromycin in Japan following successful completion of a Phase 1 study.
CEMP: 20.66 (+0.78)
Laparoscopy Devices Market - Global Industry Analysis to 2019
M2 - Mon Sep 01, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvzpjh/laparoscopy) has announced the addition of the "Laparoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global laparoscopy devices market was valued at USD 7.5 billion in 2012 and is expected to grow at a CAGR of 7.1% from 2013 to 2019, to reach an estimated value of USD 12.3 billion by 2019. The global laparoscopy devices market comprises of equipment such as laparoscope, irrigation system, insufflation devices, trocars, sample retrieval bag, wound protector, internal closure devices, gastric band, hand-assist devices, and energy systems. The segments accounting for large shares in the market include energy systems, trocars, internal closure devices and laparoscope. Although the global market is exhibiting healthy growth rate of 7.1% CAGR over the forecast period, its growth is restrained by certain side effects of laparoscopic procedures, risk of carbon dioxide emissions, and rapidly changing technologies. Introduction of newer technologies will create need for adaptive endoscope accessories. The introduction of innovative techniques such as HD systems in diagnostic instruments, HD cameras and HDTV three chip systems the demand for advanced endoscopy devices have been triggered and this scenario will continue in future. On the basis of applications, the global market for laparoscopy devices is segmented into five major segments, namely, general surgery, bariatric surgery, colorectal surgeries, urological and gynecological surgeries. General surgery accounts for the largest share in the market but the bariatric surgery is the fastest growing application segment immediately followed by colorectal surgery application. The increasing adoption of laparoscopic surgeries for colorectal cancer treatment is due to smaller incisions compared to open colectomy which results into faster recovery and less pain after surgery. Report Scope Laparoscopy Devices Market - Laparoscopes - Irrigation Systems - Insufflation Devices - Trocars - Sample Retrieval Bags - Wound Protectors - Internal Closure Devices - Gastric Bands - Hand-Assist Devices - Energy Systems Company Profiles - Braun Melsungen AG - Boston Scientific Corporation - Cook Medical, Inc. - Covidien PLC - FUJIFILM Holdings Corporation - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Smith & Nephew PLC - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/mv...aparoscopy
BSX: 13.13 (+0.07), SNN: 38.18 (+0.14), SYK: 96.00 (-0.61)
Japan ready to offer flu drug for Ebola treatment
By MARI YAMAGUCHI - AP - Mon Aug 25, 12:44PM CDT
TOKYO (AP) — Japan said Monday it is ready to provide a Japanese-developed anti-influenza drug as a possible treatment for the rapidly expanding Ebola outbreak.
How Will Fujifilm (FUJIY) Stock Be Boosted By Ebola Drug Approval?
at The Street - Thu Aug 07, 11:54AM CDT
U.S. government researchers are working to get an experimental flu drug from the Japan-based company quickly approved to treat Ebola.
Fujifilm's Q1 Earnings Rise; Revenues Drop Year over Year - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:35AM CDT
Fujifilm (FUJIY) reports mixed results for fiscal first-quarter 2015, with year over year improvement in net income while revenues declined.
AIXG: 10.99 (-0.04), MKSI: 37.24 (-0.01)
TriQuint Beats on Q2 Earnings; Bullish Outlook for 2H14 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:20PM CDT
TriQuint (TQNT) reported adjusted earnings of 13 cents per share, beating the Zacks Consensus Estimate of 3 cents. The company benefited from its portfolio restructuring efforts toward higher-value solutions.
TQNT: 27.72 (+0.50), YELP: 53.00 (-0.36), RFMD: 16.59 (+0.29)
Why FUJIFILM Holdings (FUJIY) is Such a Great Value Stock Pick Right Now - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 14, 7:37AM CDT
FUJIFILM Holdings (FUJIY) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and of late, it is seeing solid earnings estimate revisions as well.
